55
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

      review-article
      Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC), Korea
      Gut and Liver
      Editorial Office of Gut and Liver
      Diagnosis, Guidelines, Carcinoma, hepatocellular, Management

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.

          Related collections

          Most cited references595

          • Record: found
          • Abstract: not found
          • Article: not found

          Management of hepatocellular carcinoma.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

              Background & Aims Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. The global HCC BRIDGE study was a multiregional, large-scale, longitudinal cohort study undertaken to improve understanding of real-life management of patients with HCC, from diagnosis to death. Methods Data were collected retrospectively from January 2005 to September 2012 by chart reviews of eligible patients newly diagnosed with HCC at participating institutions. Results Forty-two sites in 14 countries contributed final data for 18 031 patients. Asia accounted for 67% of patients, Europe for 20% and North America for 13%. As expected, the most common risk factor was hepatitis C virus in North America, Europe and Japan, and hepatitis B virus in China, South Korea and Taiwan. The most common Barcelona Clinic Liver Cancer stage at diagnosis was C in North America, Europe, China and South Korea, and A in Taiwan and Japan. Across all stages, first HCC treatment was most frequently transarterial chemoembolization in North America, Europe, China and South Korea, percutaneous ethanol injection or radiofrequency ablation in Japan and resection in Taiwan. Survival from first HCC treatment varied significantly by region, with median overall survival not reached for Taiwan and 60, 33, 31, 24 and 23 months for Japan, North America, South Korea, Europe and China respectively (P < 0.0001). Conclusions Initial results from the BRIDGE study confirm previously reported regional trends in patient demographic characteristics and HCC risk factors, document the heterogeneity of treatment approaches across regions/countries and underscore the need for earlier HCC diagnosis worldwide.
                Bookmark

                Author and article information

                Journal
                Gut Liver
                Gut Liver
                Gut and Liver
                Editorial Office of Gut and Liver
                1976-2283
                2005-1212
                May 2019
                03 May 2019
                : 13
                : 3
                : 227-299
                Author notes
                Correspondence to: Korean Liver Cancer Association a-National Cancer Center, Korea b, Practice Guideline Revision Committee. aKorean Liver Cancer Association, 1527 Gangnam Finance Plaza, 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea, Tel: +82-2-313-1900, Fax: +82-2-539-5410, E-mail: klca@ 123456livercancer.or.kr . bCenter for Liver Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea, Tel: +82-31-920-1605, Fax: +82-31-920-1520, E-mail: jwpark@ 123456ncc.re.kr
                Article
                gnl-13-227
                10.5009/gnl19024
                6529163
                31060120
                e81c69ad-81a3-49f2-9c3b-4dcb16de0c61
                Copyright © 2019 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 06 January 2019
                : 24 January 2019
                Categories
                Review

                Gastroenterology & Hepatology
                diagnosis,guidelines,carcinoma,hepatocellular,management
                Gastroenterology & Hepatology
                diagnosis, guidelines, carcinoma, hepatocellular, management

                Comments

                Comment on this article